These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24885964)

  • 1. Modulation of insulin/IGFs pathways by sirtuin-7 inhibition in drug-induced chemoreistance.
    Aljada A; Saleh AM; Al Suwaidan S
    Diagn Pathol; 2014 May; 9():94. PubMed ID: 24885964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: implication for Gefitinib ('Iressa') response and resistance.
    Knowlden JM; Jones HE; Barrow D; Gee JM; Nicholson RI; Hutcheson IR
    Breast Cancer Res Treat; 2008 Sep; 111(1):79-91. PubMed ID: 17902048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2.
    Cui X; Lazard Z; Zhang P; Hopp TA; Lee AV
    Oncogene; 2003 Oct; 22(44):6937-41. PubMed ID: 14534541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line.
    Bradley LM; Gierthy JF; Pentecost BT
    J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):185-96. PubMed ID: 18337089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of both insulin receptor substrates 1 and 2 confers increased sensitivity to IGF-1 stimulated cell migration.
    de Blaquière GE; May FE; Westley BR
    Endocr Relat Cancer; 2009 Jun; 16(2):635-47. PubMed ID: 19261680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth factor-specific regulation of insulin receptor substrate-1 expression in MCF-7 breast carcinoma cells: effects on the insulin-like growth factor signaling pathway.
    Lassarre C; Ricort JM
    Endocrinology; 2003 Nov; 144(11):4811-9. PubMed ID: 12960057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. erbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell lines.
    Knowlden JM; Gee JM; Barrow D; Robertson JF; Ellis IO; Nicholson RI; Hutcheson IR
    Breast Cancer Res; 2011 Sep; 13(5):R93. PubMed ID: 21939528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autocrine IGF-I/insulin receptor axis compensates for inhibition of AKT in ER-positive breast cancer cells with resistance to estrogen deprivation.
    Fox EM; Kuba MG; Miller TW; Davies BR; Arteaga CL
    Breast Cancer Res; 2013; 15(4):R55. PubMed ID: 23844554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
    Guvakova MA; Surmacz E
    Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the insulin-like growth factors (IGFs) and the IGF-binding proteins (IGFBPs) in human gastric cancer cells.
    Yi HK; Hwang PH; Yang DH; Kang CW; Lee DY
    Eur J Cancer; 2001 Nov; 37(17):2257-63. PubMed ID: 11677116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug efflux by breast cancer resistance protein is a mechanism of resistance to the benzimidazole insulin-like growth factor receptor/insulin receptor inhibitor, BMS-536924.
    Hou X; Huang F; Carboni JM; Flatten K; Asmann YW; Ten Eyck C; Nakanishi T; Tibodeau JD; Ross DD; Gottardis MM; Erlichman C; Kaufmann SH; Haluska P
    Mol Cancer Ther; 2011 Jan; 10(1):117-25. PubMed ID: 21220496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ridaforolimus (MK-8669) synergizes with Dalotuzumab (MK-0646) in hormone-sensitive breast cancer.
    Becker MA; Hou X; Tienchaianada P; Haines BB; Harrington SC; Weroha SJ; Sathyanarayanan S; Haluska P
    BMC Cancer; 2016 Oct; 16(1):814. PubMed ID: 27765027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential roles of IRS-1 and SHC signaling pathways in breast cancer cells.
    Nolan MK; Jankowska L; Prisco M; Xu S; Guvakova MA; Surmacz E
    Int J Cancer; 1997 Sep; 72(5):828-34. PubMed ID: 9311601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of insulin receptor substrate 1 (IRS-1) in the human breast cancer cell line MCF-7 induces loss of estrogen requirements for growth and transformation.
    Surmacz E; Burgaud JL
    Clin Cancer Res; 1995 Nov; 1(11):1429-36. PubMed ID: 9815941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo.
    Lee AV; Jackson JG; Gooch JL; Hilsenbeck SG; Coronado-Heinsohn E; Osborne CK; Yee D
    Mol Endocrinol; 1999 May; 13(5):787-96. PubMed ID: 10319328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide inhibits the proliferation and invasion of pancreatic cancer cells through degradation of insulin receptor substrate-1 protein.
    Sugita H; Kaneki M; Furuhashi S; Hirota M; Takamori H; Baba H
    Mol Cancer Res; 2010 Aug; 8(8):1152-63. PubMed ID: 20663861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The IGF system in in-vitro human decidualization.
    Ganeff C; Chatel G; Munaut C; Frankenne F; Foidart JM; Winkler R
    Mol Hum Reprod; 2009 Jan; 15(1):27-38. PubMed ID: 19038974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SIRT7 depletion inhibits cell proliferation and androgen-induced autophagy by suppressing the AR signaling in prostate cancer.
    Ding M; Jiang CY; Zhang Y; Zhao J; Han BM; Xia SJ
    J Exp Clin Cancer Res; 2020 Feb; 39(1):28. PubMed ID: 32019578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The direct involvement of SirT1 in insulin-induced insulin receptor substrate-2 tyrosine phosphorylation.
    Zhang J
    J Biol Chem; 2007 Nov; 282(47):34356-64. PubMed ID: 17901049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines.
    Jackson JG; Zhang X; Yoneda T; Yee D
    Oncogene; 2001 Nov; 20(50):7318-25. PubMed ID: 11704861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.